(Q35779673)

10 August 2017

1 reference

title

Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme (English)

1 reference

10 August 2017

Khan F

1

1 reference

10 August 2017

Agarwal A

series ordinal

2

1 reference

10 August 2017

Agrawal S

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

10 August 2017

number of pages

12

1 reference

Bone Marrow Transplantation

inferred from page(s)

published in

1 reference

10 August 2017

volume

34

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

1-12

1 reference

Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic mye

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Immunodominant minor histocompatibility antigens: the major ones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Development of allogeneic hematopoietic stem cell transplantation (HSCT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Poor engraftment after allogeneic bone marrow transplantation: role of chimerism analysis in treatment and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Follow-up of chimerism, including T- and B-lymphocytes and granulocytes in children more than one year after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Effects of mixed chimerism and immune modulation on GVHD, disease recurrence and survival after HLA-identical marrow transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Quantitative polymerase chain reaction assessment of chimerism in non-human primates after sex-mismatched islet and bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Detection of chimaerism after bone marrow transplantation using the double amplification refractory mutation system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Flow cytometric method for the routine follow-up of red cell populations after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

The sickle cell hemolytic transfusion reaction syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

8;21 and 15;17 translocations: abnormalities in a single cell lineage in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Molecular assessment of post-BMT chimerism using various biologic specimens and automated DNA sizing technology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Restriction endonuclease in situ digestion (REISD) and fluorescence in situ hybridization (FISH) as complementary methods to analyze chimerism and residual disease after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Disparate lympho-erythroid donor to recipient chimaerism in a beta(0)-thalassaemia bone marrow transplant recipient with red cell indices indicative of apparent full engraftment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Application of a polymorphic Y microsatellite to the detection of post bone marrow transplantation chimaerism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Follow-up of chimerism in children with hematological diseases after allogeneic hematopoietic progenitor cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Recurrence of Philadelphia chromosome-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704525

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704525

1 reference

10 August 2017

1 reference